In the United States, aflibercept-yszy received Food and Drug Administration (FDA) approval in May 2024 as a biosimilar to ...
Stocks are drifting in early trading on Wall Street as U.S. markets reopen after a three-day holiday weekend. The S&P 500 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results